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MOVEMENT DISORDER ASSOCIATED WITH CELIAC
DISEASE AND THYROID DYSFUNCTION:CASE REPORT
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ABSTRACT:
Autoimmune movement disorders are uncommon yet likely treatable conditions. It is challenging to diagnose and 
manage these disorders, ultimately leading to a significant morbidity in terms of functional disability of patient. It is 
troublesome for practicing neurologists to identify whether the antibodies which are detected during the work up of 
these autoimmune movement disorders are merely incidental or have pathogenic role. This will help them to decide 
regarding whether to start immunotherapy or not. Here we have discussed two patients of movement disorder who 
were found to have positive work up for other autoimmune diseases. Available Literature on autoimmune movement 
disorder is very limited and further research on large scale is needed.
KEY WORDS: Autoimmune movement disorder, autoimmune dystonia, gluten ataxia, celiac disease, thyroid 
dysfunction 
BACKGROUND: Autoimmune movement disorders comprises of a widespread group of neurologic disorders which 
occur either in isolation or along with more diffuse autoimmune illnesses. The exact incidence and prevalence of 
autoimmune movement disorders is not known as it’s a rare disorder and very limited data is available on it comprising 
of few case reports or small sample studies. One estimates suggest that all autoimmune diseases combined affect 
about 3% of the US population, thus approximately 10 million people.1 Many movement disorders occur due 
pathologic alterations in the basal ganglia or their connections including caudate, putamen, and pallidum , 
subthalamic nucleus, substantia nigra, pedunculopontine nucleus, although some exceptions can be present. Due to 
the fact that pure, isolated autoimmune movement disorders are uncommon, work up for other aetiologies is strongly 
recommended.2 Any movement disorder phenomenology can occue in these disorders and many of the presentations 
can mimic neurodegenerative disorders, such as Huntington disease. Disorders may be ataxic, hypokinetic 
(Parkinsonism), or hyperkinetic (myoclonus, chorea, and other dyskinetic disorders3,4.
Movement disorders are commonly detected in autoimmune diseases. Chorea may present in patients with 
anti-NMDAR encephalitis, Sydenham disease, lupus and anti-phospholipid syndrome. Dystonic seizures and 
neuromyotonia may precede autoimmune encephalitis. Anti-glycine antibodies are encountered in the pathogenesis of 
progressive encephalomyelitis presenting with rigidity and myoclonus. Hashimoto's encephalitis and 
opsoclonus-myoclonus syndrome have commonly tremor and myoclonus. Few case reports and review articles also 
highlight the association of Celiac disease and autoimmune thyroid disorders with autoimmune movement disorders 5 
6. Celiac disease (CD)  approximately accounts for up to 10% of neurological manifestations irrespective to the 
presence of malabsorption symptoms7 According to an article published in 2018, in patients with autoimmune 
disorders affecting the central and peripheral nervous system, movement disorder are frequent. They may be found in 
autoimmune disorders incited by an infectious agent, like streptococcus in Sydenham's chorea, or in basal ganglia 
encephalitis with antibodies against the dopamine-D2 receptors.In these scenarios, chorea or dystonia are usually the 
most prominent.In diffuse or limbic encephalitis with antibodies directed against neuronal cell-surface antigens , 
patients also have MD. Anti-NMDA receptor encephalitis is one of the most common and may present with a variety 
of MDs, including: chorea, stereotypies, dystonia and myorhythmia while in stiff-person syndrome or cerebellar ataxia 
, intracellular enzyme glutamic acid decarboxylase are found most commonly. 8 Clues of when to suspect an 
autoimmune etiology are Female patient , Subacute onset, variable course of disease , neurological disease with 
multiple foci  , autoimmunity personal or family history , Patient having history of cancer or suspicion of new cancer 
,Abnormal laboratory supportive tests, i.e., Cerebrospinal fluid , imaging and the response to immunotherapy.2 A rapid 
diagnosis of an autoimmune disorder is utmost as early therapeutic intervention improves long-term prognosis and 
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may be life-saving. Treatment usually comprises of some form of immunotherapy and symptomatic therapy of the 
abnormal movements with dopamine depleters, dopamine receptor antagonists, or GABAergic drugs. Early-initiated 
immunotherapy leads to the best possible outcomes. Moreover, depending on the antibody profile, a search for cancer 
may be necessary followed by removal of an underlying tumour for optimal outcome.3,4 It is challenging to diagnose 
such autoimmune disorders due to the delayed clinical suspicion, improper approach to get the relevant systematic 
work up and lack of facilities for specific antibodies detection or in paraneoplastic cases getting extensive work up for 
occult neoplasm. The whole work up is expensive and time consuming ending mostly in lost to follow up of patients. 
For instance,   in literature, work up suggested for autoimmune movement disorder include CRMP-5, ANNA-1 (Hu), 
ANNA-2 (Ri), GAD65, VGCC antibodies for chorea, ANNA-2 (Ri), CRMP-5, NMDA-R, GAD65, DPPX antibodies for 
myoclonus, NMDA-R for dyskinesia ,LGI1, GAD65 for Parkinsonism,GAD65, DPPX, Amphiphysin for Stiff-Person 
Spectrum Disorders,ANNA-1 (Hu), PCA-1 (Yo), GAD65,  VGCC, CASPR2, mGluR1, DPPX for ataxia3,4 Despite all these 
limitations in diagnosis, early management is very important.
CASE 1:
26 years old female patient with no known previous comorbid, married, mother of 2 children up and about till 2 years 
back. She had history of fever 2 years back which was intermittent, high grade for which she was treated empirically. 
Fever subsided in few days but she started complaining of difficulty in speech, tremors of neck and upper limbs along 
with paroxysmal abnormal involuntary twisting and posturing of limbs characterized as dystonic posturing of limbs. Her 
tremors were characterized as rhythmical oscillatory abnormal involuntary movements of neck in horizontal direction 
present at rest while with action and intention becomes increased in amplitude and frequency. Her symptoms 
progressively increased and she started having vertigo and limb and truncal ataxia leading to difficulty in walking. No 
family history of any neurological disease. Her work up showed Hemoglobin ( Hb) 10.6 g/dl (12-15 g/dl) with normal 
total leukocyte count (TLC ) and Platelet count , Erythrocytic sedimention rate (ESR ) 55 mm/Ist hour(0-25 mm/hr). 
Peripheral film showed hypochromia, anisocytosis and poikilocytosis. Thyroid profile repeatedly showed low Thyroid 
stimulating hormone TSH  0.16 microunit /ml(0.25-4.0 microunits/ml) with normal Free triiodothyronine (Free T3) and 
Free Thyroxine (Free T4 levels). Patient had complaints of palpitations, weight loss and tremors which favours her 
thyroid disorder. As she had symptomatic thyroid disorder, possibility of sick euthyroidism is ruled out. Her thyroglobulin 
autoantibodies and thyroid peroxidase autoantibodies turned out negative. Ultrasound thyroid gland showed slightly 
enlarged both lobes of thyroid glands with non-homogenous texture. Findings concluded as diffuse goiter most 
probably associated with thyroiditis. Antinuclear antibodies (ANA) profile (which include ANA, antimitochondrial 
antibodies (AMA, anti smooth muscle antibodies ASMA) and Anti-double stranded DNA antibodies (AntiDsDNA)  were 
negative. Vitamin B12 level was 626 pg/ml (181-906 pg/ml ).  Wilson disease work up was negative including serum 
ceruloplasmin level and 24 hours urinary copper. Creatine phosphokinase (CPK) level normal. Patient had history of 
occasional diarrhoea and undocumented weight loss for 2 to 3 years. Anti - tissue transglutaminase Ig A reactive while 
Anti tissue transglutaminase IgG non- reactive. MRI brain showed prominence of cerebellar folia and dilatation of fourth 
ventricle consistent with cerebellar degeneration and atrophy. Repeat MRI brain after 8 months showed 
re-demonstration of findings of cerebellar atrophy. Patient was started on amantadine 100 mg twice daily 
,trihexiphenydyl 2 mg twice daily titrated to thrice daily dose,  propranolol 10 mg thrice daily , vitamin E 600 mg twice 
daily  and supportive treatment along with rehabilitation including gait training and balancing exercises. Gluten free diet 
was advised. Endocrinology review was taken for thyroiditis who started prednisolone 1 mg/kg/day. After 4 weeks of 
follow up patient showed some improvement in her tremors, ataxia and dystonia.
CASE 2:
35 years old male patient of average height and weight presented with continual abnormal involuntary , non 
rhythmical, non-stereotypical  movement of tongue and  jaw with some twisting and posturing characterized as 
oromandibular dystonia, slurred  speech consistent with   dysarthia, bradykinesia (slowness of movements), and 
difficulty in walking along with right leg dystonic posturing for last 2 years. No family history of any neurological 
complaint. He did not use any antipsychotic. No symptoms of hypothyroidism, myopathy and malabsorption were 
present on detailed history. His work up showed normal Complete blood count (CBC), ESR  5 mm/hr (0-25 mm/hr). 
TSH  68.90 microunits/ml (0.25-4.0 microunits/ml) , FT3 1.93 pg/ml (2.0-4.25 pg/ml), FT4  0.01 pg/ml (7- 18 pg/ml) 
Anti thyroid peroxidase antibodies (Anti TPO)  > 1000.0 IU/ml means highly positive (<5.61IU/ml),  Vitamin B12 
136pg/ml (181-906 pg/ml )which was replaced , vitamin D level 18.0 ng/ml ( upto 30 ng/ml), CPK level of 3330 U/L 
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(male 24 -195 U/L)which on repeat testing found to be 10,400 U/L ,anti Transglutaminase  IgG 0.304 ( cut off 0.304 
by ELISA) and IgA  0.316 (cut off O.212 by  ELISA )  were positive  ,Fasting lipid profile serum cholesterol 221 mg 
%(<200 mg%) LDL 151 mg% (upto 100 mg %). His serum ceruloplasmin 0.29 g/L (male 0.15-0.30 g/L), 24 hours 
urinary copper 48 ug/day (<60 ug/day), SGPT 32U/L (<40 U/L). ANA was positive. Magnetic resonance imaging (MRI) 
brain showed prominence of the cortical sulci and ventricles representing brain involution not corresponding to 
patient’s age (figure 1) .Patient was on thyroxin 100  ug per day , levodopa/carbidopa 25/250 mg half tablet thrice a 
day (TDS) and trihexiphenidyl 2 mg half TDS titrated upto 2 mg TDS ,Baclofen 10 mg half BD titrated gradually to 1 
TDS  along with rehabilitation . After a follow up of 4 weeks, his oromandibular dystonia improved to some extent but 
no significant improvement in his leg dystonia and bradykinesia .Whether patient should be started on glutein free diet 
as he was asymptomatic for coeliac disease and immunotherapy on the basis of work up or not to improve patient’s 
dystonia was still undecided. According to the available literature patient was planned for immunotherapy with regular 
follow up of his symptoms for the response. 
FIGURE 1: MRI T2W image of case 2 showing prominence of the cortical sulci and 
ventricles representing brain involution not corresponding to patient’s age (Blue arrows) 
.Hyper intense signal are seen in bilateral basal ganglia (Red arrows).
DISCUSSION
Autoimmune movement disorders in neurology are emerging and likewise the associated 
autoantibodies which need to be worked up. A number of essential tests as the supportive 
evidence are recommended to be performed in case of suspected autoimmune movement 
disorder. Antibody-related dystonia differs from primary dystonia, as it follows a characteristic 
pattern in body parts affected and age at onset. In a patient with adult onset dystonia, 
secondary causes of dystonia are more common. Work up is needed for the secondary causes 
which turned out to be autoimmune in origin as our patient had significant abnormalities in work up which suggest a 
systemic autoimmune involvement. Antibody associated dystonia typically presents as a combined dystonia means in 
combination with further clinical signs, in particular encephalopathy 9 Neurodegeneration as evident on MRI brain of 
my case 2 patient with OMD and limb dystonia is supporting this feature. Moreover he was asymptomatic for celiac 
disease and thyroid disorder and surprisingly had very high CPK without any evidence of myopathy. 
American academy of neurology published a small study in 2019 comprising of 4 patients diagnosed with autoimmune 
dystonia. Generalized asymmetric dystonia was the most common presentation, and parkinsonian symptoms (rigidity 
and resting tremors) were present in 1 patient. serum and cerebrospinal autoimmune encephalitis work up were 
inconclusive. All patients were treated with Immunotherapy using intravenous methylprednisolone 1 g daily for 5 days 
and intravenous immunoglobulin 0.4 gm/kg for 5 days, followed by azathioprine maintenance dose (2 mg/kg). 
Improvement was found in all cases with complete resolution of autoimmune dystonia in 2 cases. Hence, it was 
concluded that despite a significant delay in therapy due to misdiagnosis, autoimmune dystonia patients may respond 
well to immunomodulators with an encouraging outcome 10. Among the disorders associated with autoimmune disease 
, Celiac disease (CD) is emerging as being frequently reported with  significantly increased prevalence in individuals 
with CD and their first-degree relatives as compared to controls 11-13 .The estimated burden of Autoimmune disease 
(AD)  in CD cases up to 15% 10.It has a wide clinical spectrum which includes specific  features of  malabsorption with 
diarrhoea, non-specific  extra intestinal features, subclinical or asymptomatic variants , and likely  disease 
characterized by positive serology with a normal biopsy of intestinal mucosa 14,15. The risk factors for developing other 
AD are an early diagnosis and a positive family history of autoimmunity, whereas the gluten-free diet (GFD) has a 
beneficial role16. Another article concluded that autoimmune movement disorders with an extracellular antibody and 
without cancer are more likely to respond to treatment while the disorders with a cancer and/or an intracellular 
antibody respond less well to immunotherapy 2 .Furthermore, while a GFD is found to improve and reverse symptoms 
of gluten-associated ataxia and is an established therapy for CD, it is not the case with oromandibular dystonia (OMD). 
CD has been found increasingly in patients with autoimmune thyroid disease i.e. Grave’s disease and Hashimoto’s 
thyroiditis ,having  a 2% to 7%  prevalence 5 .Several mechanisms are suggested  about the co-occurrence  of CD and 
autoimmune thyroid disease like   similar genetic predisposition and both having the gene encoding cytotoxic 
T-lymphocyte-associated antigen .In addition, tTG2 IgA antibodies has been shown to react with thyroid tissue, leading 
to the development of thyroid disease in CD.In our both cases patients had positive work up for celiac disease as well 
as had evidence of thyroid dysfunction along with the movement disorder. 
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In 2017, “Isolated Neurological Manifestation in Silent Celiac Disease” was published in which a case of idiopathic 
oromandibular dystonia (OMD) is discussed that was unresponsive to traditional symptomatic therapy. However, 
complete resolution of symptoms was obtained after celiac disease (CD) diagnosis and gluten free diet6. In the same 
way, our case 1 patient also showed the improvement. Association of asymptomatic high creatine phosphokinase 
(CPK) level and celiac disease or other neurological illnesses remains unexplained except for the limited clue due to 
its types CK MM, CK BB, and CK MB. Further studies are highly recommended to clarify the unexplained factors and 
further management of such cases.
CONCLUSION: 
Isolated autoimmune movement disorders are uncommon and are usually associated with other neurological features. 
A prompt and thorough work up for an underlying cause and associated neural or systemic antibodies in such 
suspected cases. Ultimately through this approach decisions can be easily taken for the treatment and prognosis of 
disease. Further studies are direly needed to clarify the issues encountered in management of such cases.
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